Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " April 08, 2009":" May 08, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia
Conditions: HIV Prevention;   HIV Infections
Intervention: Behavioral: HIV risk reduction intervention
2 Unknown  Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Condition: HIV Infections
Interventions: Drug: darunavir, ritonavir, rosuvastatin;   Drug: rosuvastatin, darunavir, ritonavir
3 Active, not recruiting Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients
Conditions: HIV Infections;   Memory
Intervention:
4 Completed Linkage to Care - Part II
Conditions: HIV;   Care-seeking;   HIV Infections
Interventions: Other: Case Management;   Other: Snowball sampling;   Other: Referral Lists
5 Completed Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects
Condition: HIV Infections
Intervention: Drug: Maraviroc
6 Completed Empowerment Intervention for Young Women - Phase I
Conditions: HIV;   Empowerment;   HIV Infections
Intervention: Behavioral: Prevention Empowerment Intervention for Young Women
7 Completed
Has Results
Atazanavir and Lamivudine for Treatment Simplification
Condition: HIV Infections
Interventions: Drug: Lamiduvine (Epivir);   Drug: Atazanavir (Reyataz);   Drug: Ritonavir (Norvir)
8 Completed
Has Results
Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: Study NNRTI;   Drug: Study PI
9 Completed TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)
Condition: HIV Infections
Intervention: Drug: TMC207; nevirapine
10 Completed Dose Reduction of Lopinavir in Children
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir standard dose According to WHO simplified dosing table;   Drug: Lopinavir/ritonavir low dose ( 70% of WHO recommended dosing table)
11 Unknown  Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children
Conditions: HIV;   HIV Infections
Intervention: Behavioral: MISC training for primary caregivers
12 Completed
Has Results
A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.
Condition: HIV Infections
Interventions: Drug: Nevirapine Immediate Release (IR);   Drug: Nevirapine Extended Release (XR)
13 Completed Hepatitis B Vaccination (HBV) in HIV Infected Children
Condition: HIV Infections
Interventions: Biological: Intradermal HBV 1 course;   Biological: Intramuscular HBV I course
14 Unknown  Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir/emitricitabine);   Drug: Kaletra (lopinavir/ritonavir)
15 Completed Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil
Conditions: HIV Infection;   HIV Infections
Interventions: Behavioral: HIV Prevention Intervention - Project PRISSMA - HIV I have my eye on you;   Behavioral: Health Promotion Intervention
16 Completed
Has Results
Triomune Bioequivalence With Innovators
Condition: HIV/AIDS
Interventions: Drug: Triomune;   Drug: Zerit/Epivir/Viramune
17 Completed
Has Results
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Atazanavir (ATV) 300 mg;   Drug: Atazanavir (ATV) 400 mg;   Drug: Ritonavir (rtv) 100 mg;   Drug: Nucleo(side)/(tide) reverse transcriptase inhibitors (NRTIs);   Drug: Etravirine (ETR) 200 mg;   Drug: Tenofovir disoproxil fumarate (TDF) 300 mg
18 Active, not recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
19 Completed Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid
Conditions: Human Immunodeficiency Virus Infections;   HIV Infections
Interventions: Biological: tgAAC09;   Other: Formulation buffer
20 Completed Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: ritonavir-boosted PI-based second line treatments;   Drug: two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.